CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: 1,3-difluorobenzene
Accession: CHEBI:38584
browse the term
Definition: A difluorobenzene carrying fluoro groups at positions 1 and 3.
Synonyms: related_synonym: 1,3-Difluorbenzol; Formula=C6H4F2; InChI=1S/C6H4F2/c7-5-2-1-3-6(8)4-5/h1-4H; InChIKey=UEMGWPRHOOEKTA-UHFFFAOYSA-N; SMILES=Fc1cccc(F)c1; m-difluorobenzene; meta-difluorobenzene
xref: Beilstein:1904537; CAS:372-18-9; Gmelin:200891; PMID:15535712; PMID:22707282; Patent:CN101607874; Patent:CN1634895; Patent:CN1765887; Reaxys:1904537
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression
EXP
Diflubenzuron results in increased expression of CYP1A1 protein
CTD
PMID:8812189
NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
affects binding
ISO
Diflubenzuron binds to CYP1A2 protein
CTD
PMID:32278787
NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301
G
Cyp3a23-3a1
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1
increases expression
EXP
Diflubenzuron results in increased expression of CYP3A23-3A1 protein
CTD
PMID:8812189
NCBI chr12:11,053,888...11,082,742
Ensembl chr12:11,655,402...11,733,136
G
Cyp3a62
cytochrome P450, family 3, subfamily a, polypeptide 62
affects binding
ISO
Diflubenzuron binds to CYP3A4 protein
CTD
PMID:32278787
NCBI chr12:18,679,809...18,709,397
Ensembl chr12:18,678,594...18,709,397
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
increases activity
ISO
Diflubenzuron results in increased activity of NR1I2 protein
CTD
PMID:16565514
NCBI chr11:65,022,100...65,058,546
Ensembl chr11:65,022,100...65,058,545
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Diflunisal results in increased expression of FOS mRNA
CTD
PMID:12730611
NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
G
Il1b
interleukin 1 beta
increases expression
EXP
Diflunisal results in increased expression of IL1B mRNA
CTD
PMID:15135310
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
G
Il6
interleukin 6
increases expression
EXP
Diflunisal results in increased expression of IL6 mRNA
CTD
PMID:15135310
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
G
LOC100364500
RT1 class I, locus CE11-like
affects expression
ISO
Diflunisal affects the expression of HLA-A mRNA
CTD
PMID:25811541
NCBI chr20:2,704,153...2,707,111
Ensembl chr20:2,704,148...2,707,120
G
Nos2
nitric oxide synthase 2
increases expression
EXP
Diflunisal results in increased expression of NOS2 mRNA
CTD
PMID:15135310
NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190
G
Tnf
tumor necrosis factor
increases expression
EXP
Diflunisal results in increased expression of TNF mRNA
CTD
PMID:15135310
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
G
Ttr
transthyretin
affects binding multiple interactions
ISO
Diflunisal binds to TTR protein mutant form [Diflunisal binds to TTR protein mutant form] which results in decreased susceptibility to Urea; Diflunisal results in increased stability of [TTR protein binds to TTR protein binds to TTR protein binds to TTR protein]
CTD
PMID:17701470 PMID:27093678
NCBI chr18:15,532,963...15,542,180
Ensembl chr18:15,532,963...15,540,177
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
decreases activity
ISO
Diflunisal results in decreased activity of UGT1A1 protein
CTD
PMID:15593333
NCBI chr 9:95,295,701...95,302,822
Ensembl chr 9:95,161,157...95,302,822
G
Ugt1a2
UDP glucuronosyltransferase 1 family, polypeptide A2
increases glucuronidation
ISO
UGT1A3 protein results in increased glucuronidation of Diflunisal
CTD
PMID:15117964
NCBI chr 9:95,285,592...95,302,822
Ensembl chr 9:95,161,157...95,302,822
G
Ugt1a8
UDP glucuronosyltransferase family 1 member A8
increases glucuronidation
ISO
UGT1A8 protein results in increased glucuronidation of Diflunisal
CTD
PMID:15117964
NCBI chr 9:95,221,474...95,302,822
Ensembl chr 9:95,161,157...95,302,822
G
Ugt2b7
UDP glucuronosyltransferase family 2 member B7
multiple interactions increases glucuronidation
ISO
Diflunisal inhibits the reaction [UGT2B7 protein results in increased chemical synthesis of aldosterone 18-glucuronide]; Diflunisal inhibits the reaction [UGT2B7 protein results in increased glucuronidation of Aldosterone] UGT2B7 protein alternative form results in increased glucuronidation of Diflunisal; UGT2B7 protein results in increased glucuronidation of Diflunisal
CTD
PMID:8423545 PMID:8517101 PMID:19740398
NCBI chr14:22,597,103...22,619,968
G
Abcb9
ATP binding cassette subfamily B member 9
decreases expression
EXP
Fluconazole results in decreased expression of ABCB9 mRNA
CTD
PMID:16643972
NCBI chr12:37,923,974...37,956,678
Ensembl chr12:37,923,528...37,958,363
G
Adh1
alcohol dehydrogenase 1 (class I)
decreases expression
EXP
Fluconazole results in decreased expression of ADH1 mRNA
CTD
PMID:16643972
NCBI chr 2:243,550,655...243,562,243
Ensembl chr 2:243,550,627...243,687,857
G
Akr7a3
aldo-keto reductase family 7 member A3
increases expression
EXP
Fluconazole results in increased expression of AKR7A3 mRNA
CTD
PMID:16643972
NCBI chr 5:157,801,120...157,813,756
Ensembl chr 5:157,801,163...157,813,756
G
Apoa4
apolipoprotein A4
decreases expression
EXP
Fluconazole results in decreased expression of APOA4 mRNA
CTD
PMID:16643972
NCBI chr 8:50,536,983...50,539,371
Ensembl chr 8:50,537,009...50,539,376
G
Ces2h
carboxylesterase 2H
increases expression
EXP
Fluconazole results in increased expression of CES2 mRNA
CTD
PMID:16643972
NCBI chr19:37,052,555...37,067,176
Ensembl chr19:37,052,556...37,067,156
G
Cyp17a1
cytochrome P450, family 17, subfamily a, polypeptide 1
affects activity
ISO
Fluconazole affects the activity of CYP17A1 protein
CTD
PMID:31330226
NCBI chr 1:266,422,127...266,429,947
Ensembl chr 1:266,422,132...266,428,239
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
multiple interactions decreases activity
ISO
[Fluconazole results in decreased activity of CYP19A1 protein] which results in decreased chemical synthesis of Estrone; [Fluconazole results in decreased activity of CYP19A1 protein] which results in decreased metabolism of Androstenedione
CTD
PMID:31330226
NCBI chr 8:58,744,849...58,772,408
Ensembl chr 8:58,744,849...58,772,408
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases expression
ISO
Fluconazole results in increased expression of CYP1A2 mRNA
CTD
PMID:16730040
NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301
G
Cyp26a1
cytochrome P450, family 26, subfamily a, polypeptide 1
increases expression
ISO
Fluconazole results in increased expression of CYP26A1 mRNA
CTD
PMID:19429397
NCBI chr 1:256,382,861...256,386,729
Ensembl chr 1:256,382,791...256,386,729
G
Cyp26b1
cytochrome P450, family 26, subfamily b, polypeptide 1
increases expression
ISO
Fluconazole results in increased expression of CYP26B1 mRNA
CTD
PMID:19429397
NCBI chr 4:116,261,796...116,278,615
Ensembl chr 4:116,261,796...116,278,615
G
Cyp2b1
cytochrome P450, family 2, subfamily b, polypeptide 1
multiple interactions increases expression
ISO
NR1I3 promotes the reaction [Fluconazole results in increased expression of CYP2B10 mRNA]
CTD
PMID:16730040 PMID:25656644
NCBI chr 7:99,142,431...99,183,540
Ensembl chr 7:99,142,450...99,181,783
G
Cyp2c11
cytochrome P450, subfamily 2, polypeptide 11
decreases expression
EXP
Fluconazole results in decreased expression of CYP2C mRNA
CTD
PMID:16643972
NCBI chr 1:257,676,172...258,004,428
Ensembl chr 1:257,970,345...258,004,434
G
Cyp2c24
cytochrome P450, family 2, subfamily c, polypeptide 24
increases expression
ISO
Fluconazole results in increased expression of CYP2C55 mRNA
CTD
PMID:16730040
NCBI chr 1:258,074,797...258,139,176
Ensembl chr 1:258,074,860...258,139,176
G
Cyp2c6v1
cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1
decreases activity multiple interactions increases metabolic processing
ISO
Fluconazole results in decreased activity of CYP2C19 protein [Fluconazole results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole CYP2C19 protein results in increased metabolism of Fluconazole
CTD
PMID:12464242 PMID:15843491 PMID:17702393 PMID:19328226 PMID:26599973
NCBI chr 1:147,713,879...147,814,410
Ensembl chr 1:147,713,892...147,888,007
G
Cyp2c79
cytochrome P450, family 2, subfamily c, polypeptide 79
increases expression
ISO
Fluconazole results in increased expression of CYP2C29 mRNA
CTD
PMID:16730040
NCBI chr 1:147,236,480...147,307,988
G
Cyp2g1
cytochrome P450, family 2, subfamily g, polypeptide 1
decreases expression
EXP
Fluconazole results in decreased expression of CYP2G1 mRNA
CTD
PMID:16643972
NCBI chr 1:83,626,639...83,638,154
Ensembl chr 1:83,626,639...83,637,780
G
Cyp2j4
cytochrome P450, family 2, subfamily j, polypeptide 4
decreases expression
ISO
Fluconazole results in decreased expression of CYP2J9 mRNA
CTD
PMID:16730040
NCBI chr 5:119,546,458...119,564,843
Ensembl chr 5:119,546,461...119,564,846
G
Cyp3a23-3a1
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1
increases expression affects expression
EXP
Fluconazole results in increased expression of CYP3A23-3A1 mRNA Fluconazole affects the expression of CYP3A23-3A1 mRNA
CTD
PMID:16643972 PMID:20623750
NCBI chr12:11,053,888...11,082,742
Ensembl chr12:11,655,402...11,733,136
G
Cyp3a62
cytochrome P450, family 3, subfamily a, polypeptide 62
decreases activity
ISO
Fluconazole results in decreased activity of CYP3A4 protein
CTD
PMID:15784650 PMID:15843491
NCBI chr12:18,679,809...18,709,397
Ensembl chr12:18,678,594...18,709,397
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
increases expression
EXP
Fluconazole results in increased expression of CYP3A13 mRNA
CTD
PMID:16643972
NCBI chr12:19,074,288...19,114,491
Ensembl chr12:19,074,583...19,114,399
G
Cyp51
cytochrome P450, family 51
decreases activity decreases response to substance multiple interactions
ISO
Fluconazole results in decreased activity of CYP51A1 protein CYP51A1 gene results in decreased susceptibility to Fluconazole CYP51A1 gene inhibits the reaction [Fluconazole results in decreased chemical synthesis of Ergosterol]; CYP51A1 gene inhibits the reaction [Fluconazole results in decreased metabolism of and results in increased abundance of 14-methylergosta-8,24(28)-dien-3,6-diol]; CYP51A1 gene inhibits the reaction [Fluconazole results in decreased metabolism of and results in increased abundance of Lanosterol]
CTD
PMID:16989930 PMID:18694951
NCBI chr 4:27,175,564...27,194,018
Ensembl chr 4:27,175,243...27,194,018
G
Gstm1
glutathione S-transferase mu 1
increases expression
ISO
Fluconazole results in increased expression of GSTM1 mRNA
CTD
PMID:16730040
NCBI chr 2:210,803,869...210,809,461
Ensembl chr 2:210,803,869...210,809,306
G
Jund
JunD proto-oncogene, AP-1 transcription factor subunit
decreases expression
EXP
Fluconazole results in decreased expression of JUND mRNA
CTD
PMID:16643972
NCBI chr16:20,485,028...20,486,707
Ensembl chr16:20,485,029...20,486,707
G
Lcn2
lipocalin 2
increases expression
EXP
Fluconazole results in increased expression of LCN2 mRNA
CTD
PMID:20623750
NCBI chr 3:11,414,189...11,417,534
Ensembl chr 3:11,414,186...11,417,546
G
Mark2
microtubule affinity regulating kinase 2
increases expression
ISO
Fluconazole results in increased expression of MARK2 mRNA
CTD
PMID:16730040
NCBI chr 1:222,525,547...222,590,727
Ensembl chr 1:222,525,990...222,590,220
G
Mpo
myeloperoxidase
increases expression
EXP
Fluconazole results in increased expression of MPO mRNA
CTD
PMID:20623750
NCBI chr10:75,087,892...75,098,260
Ensembl chr10:75,087,892...75,098,260
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions
ISO
Fluconazole inhibits the reaction [Rifampin results in increased activity of NR1I2 protein]
CTD
PMID:17438109
NCBI chr11:65,022,100...65,058,546
Ensembl chr11:65,022,100...65,058,545
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
affects response to substance increases response to substance multiple interactions
ISO
NR1I3 protein affects the susceptibility to Fluconazole NR1I3 results in increased susceptibility to Fluconazole NR1I3 promotes the reaction [Fluconazole results in increased expression of CYP2B10 mRNA]; NR1I3 promotes the reaction [Fluconazole results in increased expression of CYP3A11 mRNA]; NR1I3 promotes the reaction [Fluconazole results in increased expression of POR mRNA]
CTD
PMID:23721867 PMID:25656644
NCBI chr13:89,585,072...89,591,278
Ensembl chr13:89,586,283...89,591,277
G
Por
cytochrome p450 oxidoreductase
decreases expression multiple interactions increases expression
EXP ISO
Fluconazole results in decreased expression of POR mRNA NR1I3 promotes the reaction [Fluconazole results in increased expression of POR mRNA]
CTD
PMID:16643972 PMID:16730040 PMID:25656644
NCBI chr12:23,998,411...24,017,063
Ensembl chr12:23,998,411...24,046,814
G
Pparg
peroxisome proliferator-activated receptor gamma
increases expression
EXP
Fluconazole results in increased expression of PPARG mRNA
CTD
PMID:20623750
NCBI chr 4:147,274,055...147,399,383
Ensembl chr 4:147,274,107...147,399,380
G
Slc13a2
solute carrier family 13 member 2
decreases expression
ISO
Fluconazole results in decreased expression of SLC13A2 mRNA
CTD
PMID:16730040
NCBI chr10:65,664,665...65,692,046
Ensembl chr10:65,664,667...65,692,023
G
Slc6a13
solute carrier family 6 member 13
decreases expression
EXP
Fluconazole results in decreased expression of SLC6A13 mRNA
CTD
PMID:16643972
NCBI chr 4:153,874,942...153,912,185
Ensembl chr 4:153,874,852...153,912,155
G
Slco1a4
solute carrier organic anion transporter family, member 1a4
increases expression
ISO
Fluconazole results in increased expression of SLCO1A4 mRNA
CTD
PMID:16730040
NCBI chr 4:175,969,549...176,026,227
Ensembl chr 4:175,969,549...176,026,163
G
Srd5a1
steroid 5 alpha-reductase 1
decreases expression
EXP
Fluconazole results in decreased expression of SRD5A1 mRNA
CTD
PMID:16643972
NCBI chr 1:36,320,504...36,354,694
Ensembl chr 1:36,320,461...36,354,756
G
Star
steroidogenic acute regulatory protein
increases expression
ISO
Fluconazole results in increased expression of STAR mRNA
CTD
PMID:23038793
NCBI chr16:71,036,204...71,040,847
Ensembl chr16:71,036,204...71,040,847
G
Ugt1a9
UDP glucuronosyltransferase family 1 member A9
affects expression
EXP
Fluconazole affects the expression of UGT1A9 mRNA
CTD
PMID:20623750
NCBI chr 9:95,161,157...95,302,822
Ensembl chr 9:95,161,157...95,302,822
G
Ugt2b17
UDP glucuronosyltransferase family 2 member B17
increases expression
EXP
Fluconazole results in increased expression of UGT2B1 mRNA
CTD
PMID:16643972
NCBI chr14:22,724,399...22,736,148
Ensembl chr14:22,724,070...22,825,444
G
Ugt2b7
UDP glucuronosyltransferase family 2 member B7
multiple interactions
ISO
Fluconazole inhibits the reaction [[Uridine Diphosphate Glucuronic Acid co-treated with UGT2B7 protein] results in increased glucuronidation of Labetalol]
CTD
PMID:18098064
NCBI chr14:22,597,103...22,619,968
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all